Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB-AATY for Colitis ulcerative: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 122 adverse event reports in the FDA FAERS database where ADALIMUMAB-AATY was used for Colitis ulcerative.

Most Reported Side Effects for ADALIMUMAB-AATY

Side Effect Reports % Deaths Hosp.
Intentional dose omission 338 20.1% 7 112
Drug ineffective 151 9.0% 1 16
Intentional product use issue 151 9.0% 8 29
Death 132 7.9% 131 10
Arthralgia 96 5.7% 2 15
Rheumatoid arthritis 94 5.6% 5 7
Fatigue 92 5.5% 3 14
Therapy interrupted 88 5.2% 0 19
Crohn's disease 87 5.2% 3 20
Headache 86 5.1% 3 13
Accidental exposure to product 85 5.1% 2 3
Exposure via skin contact 85 5.1% 3 3
Condition aggravated 81 4.8% 6 24
Device malfunction 80 4.8% 1 2
Nausea 76 4.5% 0 11

Other Indications for ADALIMUMAB-AATY

Rheumatoid arthritis (477) Crohn's disease (320) Psoriatic arthropathy (199) Ankylosing spondylitis (147) Product used for unknown indication (144) Hidradenitis (101) Psoriasis (80) Axial spondyloarthritis (22) Uveitis (18) Juvenile idiopathic arthritis (15)

Other Drugs Used for Colitis ulcerative

ADALIMUMAB (34,530) VEDOLIZUMAB (33,987) INFLIXIMAB (21,373) INFLIXIMAB-DYYB (6,767) TOFACITINIB (6,358) MESALAMINE (6,347) UPADACITINIB (4,800) USTEKINUMAB (3,872) GOLIMUMAB (3,637) HUMIRA (2,707)

Related Pages

ADALIMUMAB-AATY Full Profile All Colitis ulcerative Drugs ADALIMUMAB-AATY Demographics ADALIMUMAB-AATY Timeline